IHS Chemical Week

Regions :: North America :: U.S.

NPIL and Napo Codevelop Drug

10:53 AM MDT | July 27, 2007 | Chemical Week Editorial Staff

Napo Pharmaceuticals (San Francisco) and Nicholas Piramal India Ltd. (NPIL; Mumbai) say they have entered into a plant-screening agreement to discover novel therapeutic compounds for treating diabetes. NPIL will use its screening facility and natural product chemistry expertize, along with its biological testing capabilities, to identify active compounds from Napo’s library of medicinal plant extracts from tropical regions. Napo and NPIL will jointly own all products that are developed under the agreement. “This agreement allows us to use our advanced...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa